SOLARA — Solara Active Pharma Sciences Share News
0.000.00%
Last trade - 00:00- IN₹29.41bn
- IN₹34.56bn
- IN₹13.69bn
Brief: Solara Active Pharma Sciences Appoints Bharath Sesha As Chief Executive Officer
Brief: Solara Active Pharma Updates On USFDA Test Results Of Ranitidine Samples
Brief: India's Solara Made API For Aussie Ranitidine Batches Found To Have Acceptable NDMA Levels
Brief: India's Solara Active Pharma Sept Qtr Profit Rises
Brief: India's Solara Active Pharma Sciences June Qtr Consol Net Profit Rises
Brief: Indian Pharma Firm Solara says Facility Completes U.S. FDA Inspection with Zero 483s
Brief: Solara Active Pharma Sciences Gets Nod To Increase Transaction Value With Strides Pharma Science
Brief: Solara Active Pharma Sciences Gets Shareholders' Nod For Issue Of Convertible Warrants
Brief: Solara Active Pharma Sciences Seeks Shareholders' Nod To Up Value Of Deals With Strides Pharma Science For FY 2018-19
Brief: Solara Active Pharma Sciences Says Got Zero 483s Post USFDA Inspection At Ambernath Facility
Brief: Solara Active Pharma Sciences To Consider Capital Raising
Brief: Solara Active Pharma Says U.S FDA Compeletes Inspection At Solara Research Centre, Chennai
Brief: Solara Active Pharma Sciences Says Mangalore Facility Receives EIR From USFDA
Brief: India's Solara Active Pharma Sciences Board Approves Amalgamation With Strides Chemicals
Brief: India's Solara Active Pharma Sciences Seeks Shareholders' Nod For Appointment Of Jitesh Devendra As Managing Director
Brief: Solara Active Pharma Sciences Seeks Shareholders' Nod To Invest In Strides Chemicals